Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety
Clinical trial NCT01142284 · COMPLETED
Trial details
- NCT number
- NCT01142284
- Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-19
- Primary completion
- 2012-11-29
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.